AstraZeneca is facing a multimillion-dollar lawsuit in the English High Court following claims that the pharmaceutical giant’s COVID-19 vaccine caused serious injuries and even death to those who received it.
The lawsuit brands the AstraZeneca vaccine – suspended by multiple countries shortly after its initial rollout – as “defective,” with claims of its efficacy being “vastly overstated.” It also takes aim at the British government, which continued providing AstraZeneca’s vaccine despite other countries having discontinued it and raises questions concerning the extent to which authorities knew of the potential risks.
The landmark case is expected to open the floodgates to dozens of similar claims worth up to $100 million in the coming months due to a new condition called “Vaccine-induced Immune Thrombocytopenia and Thrombosis (VITT)” being identified by specialists after the vaccine’s rollout.
One of the claims is brought by Jamie Scott, who suffered a life-threatening bleed on the brain as a result of the vaccination. Scott’s family is suing the pharmaceutical company due to the inadequacy of the British government’s £120,000 ($147,000) compensation payout.
“We are private people but we cannot stand the injustice of it. We have been lobbying the Government for 18 months for fair compensation for the injury caused by the vaccine,” said Scott’s wife, adding, “We were told by the Government the vaccine was safe and effective but what’s happened to Jamie has been life changing and their [AstraZeneca] vaccine caused that.”
The second claim was filed by Anish Tailor after his wife died from blood clots and bleeding on the brain after vaccination caused by VITT. The family is seeking £5 million ($6.1 million) in damages.
The pharmaceutical company said in a statement on the matter, “Patient safety is our highest priority and regulatory authorities have clear and stringent standards to ensure the safe use of all medicines, including vaccines. Our sympathy goes out to anyone who has lost loved ones or reported health problems.”